Med BioGene Inc. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.01 |
Market Cap |
CAD702.67 K |
Shares Outstanding |
13.26 M |
Public Float |
7.72 M |
Address |
598 East Kent Avenue South Vancouver British Columbia V5X 4V6 Canada |
Employees | - |
Website | http://www.medbiogene.com |
Updated | 07/08/2019 |
Med BioGene, Inc. operates as a life science company, which engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. It focuses on managing the license and rights for GeneFx Lung, prognostic genomic-based test for non-small-cell lung cancer. The company was founded on April 28, 2006 and is headquartered in Vancouver, Canada. |